- Previous Close
23.15 - Open
23.05 - Bid 22.95 x --
- Ask 23.00 x --
- Day's Range
22.95 - 23.30 - 52 Week Range
21.50 - 28.35 - Volume
99,134 - Avg. Volume
129,326 - Market Cap (intraday)
3.057B - Beta (5Y Monthly) 0.41
- PE Ratio (TTM)
17.69 - EPS (TTM)
1.30 - Earnings Date --
- Forward Dividend & Yield 1.15 (4.90%)
- Ex-Dividend Date Jun 28, 2024
- 1y Target Est
--
Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. It offers hair care products; health care products and food supplements; and mother and baby skin care products. The company also provides pharmaceuticals and medical devices, such as PG2 Lyophilized injection for treatment of cancer-related fatigue; AmCad-UT Detection device, an ultrasound CAD for thyroid cancer detection; Bio-Three tablets for the treatment of mild diarrhea, abdominal pain, and constipation; and Cerebrolysin, a supplementary nutrient boost for patients who cannot ingest adequate food and patients who have difficulties in the digestion, absorption, synthesis, and utilization of proteins, as well as for patients suffering from severe trauma, burns, fractures, insufficient protein intake, or malnutrition. In addition, it sells and distributes pharmaceutical products; and operates and manages pharmacy chain under the Pharmacy Franchise name. Maywufa Company Ltd. was founded in 1976 and is headquartered in Taipei, Taiwan.
www.maywufa.com.tw--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 1731.TW
View MorePerformance Overview: 1731.TW
Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1731.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1731.TW
View MoreValuation Measures
Market Cap
3.06B
Enterprise Value
3.12B
Trailing P/E
17.69
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.12
Price/Book (mrq)
1.48
Enterprise Value/Revenue
2.15
Enterprise Value/EBITDA
12.42
Financial Highlights
Profitability and Income Statement
Profit Margin
12.39%
Return on Assets (ttm)
4.35%
Return on Equity (ttm)
8.69%
Revenue (ttm)
1.4B
Net Income Avi to Common (ttm)
173.23M
Diluted EPS (ttm)
1.30
Balance Sheet and Cash Flow
Total Cash (mrq)
683.91M
Total Debt/Equity (mrq)
28.64%
Levered Free Cash Flow (ttm)
-148.31M